Vertex Pharma to buy Crinetics Pharmaceuticals for $10 billion: Boston Wednesday, July 8, 2026, 14:00 Hrs [IST] Vertex Pharmaceuticals Incorporated, a global biotechnology company ...

People who brought their blood sugar back to normal after a prediabetes diagnosis cut their risk of cardiovascular death or ...

In environments where software influences real clinical decisions, rigor is not optional. It is the condition that makes ...

With an increasingly aging global population and no available preventive treatments, Alzheimer's disease and related ...

The modern healthcare revenue cycle was designed around an expertise constraint. What I've come to discover is that most ...

Labor expenses for hospitals are seeing minimal growth while drug and supply expenses are rocketing across most hospital categories.

The future of equitable AI in community health centers will be measured by how effectively we are able to demand partnership ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient ...

Healthcare executive pay budgets hold at 3% while actual salaries rise near 5%, revealing key 2026 compensation trends across U.S. health systems.

Implantable brain devices—from deep brain stimulation to a new generation of brain-computer interfaces—can help people with severe, treatment-resistant psychiatric and neurological conditions or loss ...

Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex's portfolio - PALSONIFY, Crinetics' recently launched, first ...